Endocura Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 12 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth -7.16%
- Profit Growth -0.24%
- Ebitda -5.52%
- Net Worth -1.18%
- Total Assets -6.19%
About Endocura Pharma
Endocura Pharma Private Limited (EPPL) is a Private Limited Indian Non-Government Company incorporated in India on 19 March 2012 and has a history of 12 years and ten months. Its registered office is in Gwalior, Madhya Pradesh, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Geeta Chauhan, Kavita Rathore, and Himanshu Chauhan serve as directors at the Company.
Company Details
-
Location
Gwalior, Madhya Pradesh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24100MP2012PTC053144
-
Company No.
233083
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
19 Mar 2012
-
Date of AGM
26 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Gwalior
Industry
What products or services does Endocura Pharma Private Limited offer?
Endocura Pharma Private Limited offers a wide range of products and services, including Common Disease Medicines, Pharmaceutical Medicine, Nutritional Drinks, For Children.
Who are the key members and board of directors at Endocura Pharma?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Geeta Chauhan
|
Director | 19-Mar-2012 | Current |
|
Kavita Rathore
|
Director | 07-Aug-2023 | Current |
|
Himanshu Chauhan
|
Director | 30-Oct-2014 | Current |
Financial Performance of Endocura Pharma.
Endocura Pharma Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 7.16% decrease. The company also saw a slight decrease in profitability, with a 0.24% decrease in profit. The company's net worth dipped by a decrease of 1.18%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Endocura Pharma?
In 2023, Endocura Pharma had a public holding of 50.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Endocura Pharma?
Unlock and access historical data on people associated with Endocura Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Endocura Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Endocura Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.